4//SEC Filing
Bahrt Kenneth 4
Accession 0001181431-13-007059
CIK 0000722104other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 10:19 AM ET
Size
6.2 KB
Accession
0001181431-13-007059
Insider Transaction Report
Form 4
Bahrt Kenneth
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock $.01 par value per share
2013-02-04$1.01/sh−7,300$7,373→ 193,450 total - Sale
Common Stock $.01 par value per share
2013-02-04$1.04/sh−21,700$22,568→ 171,750 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001527197
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 10:19 AM ET
- Size
- 6.2 KB